Abstract 2542: Lurbinectedin (PM01183) synergizes in vivo the antitumor activity of doxorubicin in SCLC tumor xenografts von Guillen, Maria Jose, Cataluña, Oscar, Palomares, Mandy, Lopez, Raquel, Nuñez, Praxedes, Cuevas, Carmen, Aviles, Pablo M.

Volltext

Abstract A173: The new marine derived tubulin binding agent PM060184 shows potent antitumor activity in vivo against multidrug resistant, Pgp expressing tumors von Aviles, Pablo M., Guillen, Maria José, Palomares, Mandy, Nuñez, Praxedes, Martinez-Diez, Marta, Martínez-Leal, Juan Fernando, García-Fernández, Luis Francisco, Galmarini, Carlos M.

Volltext

Abstract 1779: Antitumor effect and tumor distribution of PM01183 in human pancreatic and breast xenograft mouse models von Bishop, Alan, Pernice, Tiziana, Aviles, Pablo M., Cataluña, Oscar, Palomares, Mandy, Lopez, Raquel, Nuñez, Praxedes, Cuevas, Carmen, Guillén, M José

Volltext

Abstract 4654: Plasma, tissue and tumor pharmacokinetics of PM060184 in NSCL xenograft mouse model von Pernice, Tiziana, Bishop, Alan, Cataluña, Oscar, Palomares, Mandy, Lopez, Raquel, Núñez, Práxedes, Cuevas, Carmen, Guillén, Maria José, Aviles, Pablo M.

Volltext

Abstract 5495: Lurbinectedin (PM01183) in vivo synergizes the antitumor activity of taxanes von Guillén, Maria José, Cataluña, Oscar, Palomares, Mandy, López, Raquel, Núñez, Práxedes, Cuevas, Carmen, Avilés, Pablo

Volltext

Abstract 5498: Synergism of lurbinectedin (PM01183) combined with 5-fluorouracil (5-FU): in vitro and in vivo studies von Aviles, Pablo, Guillen, Maria José, Galmarini, Carlos, García, Luis Francisco, López, Raquel, Núñez, Práxedes, Moneo, Victoria, Cuevas, Carmen

Volltext